Related Experiment Video
Updated: Oct 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to low density lipoprotein
R C Maranhão1, I A Roland, O Toffoletto
1Heart Institute of the Medical School Hospital (Instituto do Coração do HC-FMUSP, São Paulo, Brazil. Sadler@opus.com.br
Abstract:
It was previously reported that a protein-free microemulsion (LDE) with structure roughly resembling that of the lipid portion of low density lipoprotein (LDL) was presumably taken up by LDL receptors when injected into the bloodstream. In contact with plasma, LDE acquires apolipoproteins (apo) including apo E that would be the ligand for receptor binding. Currently, apo were associated to LDE by incubation with high density lipoprotein (HDL). LDE-apo uptake by mononuclear cells showed a saturation kinetics, with an apparent K(m) of 13.1 ng protein/mL. LDE-apo is able to displace LDL uptake by mononuclear cells with a Ki of 11.5 ng protein/mL. LDE without apo is, however, unable to displace LDL. The uptake of 14C-HDL is not dislocated by increasing amounts of LDE-apo, indicating that HDL and LDE-apo do not bind to the same receptor sites. In human hyperlipidemias, LDE labeled with 14C-cholesteryl ester behaved kinetically as expected for native LDL. LDE plasma disappearance curve obtained from eight hypercholesterolemic patients was markedly slower than that from 10 control normolipidemic subjects [fractional clearance rate (FCR) = 0.02 +/- 0.01 and 0.12 +/- 0.04 h-1, respectively; P < 0.0001]. On the other hand, in four severely hypertriglyceridemic patients, LDE FCR was not significantly different from the controls (0.07 +/- 0.03 h-1). These results suggest that LDE can be a useful device to study lipoprotein metabolism.
Insights
Lipoprotein-depleted emulsions (LDE) acquire apolipoproteins in plasma, mimicking low-density lipoprotein (LDL) uptake. In hypercholesterolemia, LDE clearance is slower, suggesting LDE is a valuable tool for studying lipoprotein metabolism.
Area of Science:
- Biochemistry
- Lipid Metabolism
- Pharmacology
Background:
- Lipoprotein-depleted emulsions (LDE) structurally resemble the lipid core of low-density lipoprotein (LDL).
- LDE are hypothesized to be internalized via LDL receptors after acquiring apolipoproteins (apo) from plasma, particularly apo E.
Purpose of the Study:
- To investigate the uptake mechanism and metabolic fate of LDE in vitro and in vivo.
- To assess the potential of LDE as a model system for studying lipoprotein metabolism, especially in hyperlipidemic conditions.
Main Methods:
- Assessing LDE-apo uptake kinetics and competition with LDL in mononuclear cells.
- Investigating the binding specificity of LDE-apo by examining high-density lipoprotein (HDL) uptake.
- Administering radiolabeled LDE to hypercholesterolemic and hypertriglyceridemic patients and healthy controls to determine plasma clearance rates.
Main Results:
- LDE-apo exhibited saturation kinetics in mononuclear cell uptake, with an apparent K(m) of 13.1 ng protein/mL.
- LDE-apo displaced LDL uptake (Ki = 11.5 ng protein/mL), but LDE without apo did not.
- LDE-apo did not affect 14C-HDL uptake, indicating distinct receptor binding.
- In hypercholesterolemic patients, LDE plasma disappearance was significantly slower (FCR = 0.02 h-1) compared to controls (FCR = 0.12 h-1).
- In hypertriglyceridemic patients, LDE clearance was not significantly different from controls (FCR = 0.07 h-1).
Conclusions:
- LDE, upon acquiring apolipoproteins, interacts with the LDL receptor pathway.
- The altered plasma clearance of LDE in hypercholesterolemia highlights its utility in studying lipoprotein disorders.
- LDE serves as a promising tool for investigating lipoprotein metabolism and receptor-mediated uptake mechanisms.
Related Concept Videos
Asymmetric Lipid Bilayer
Drug Distribution: Plasma Protein Binding
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles in drug...
Bioavailability Enhancement: Drug Permeability Enhancement
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

